Abstract
1. The relaxant actions of nitroglycerin (previously considered to be an endothelium-independent relaxing agent) and acetylcholine (an endothelium-dependent relaxing agent) were compared on 4 vascular preparations (dorsal pedal artery, saphenous vein, left anterior descending coronary artery and circumflex coronary artery) from dogs with and without pacing-induced congestive heart failure (CHF). 2. Responses of the coronary arteries to acetylcholine were unaltered in endothelium-intact rings from dogs with and without heart failure. Similarly no such changes were observed in the peripheral vessels. The maximum relaxation produced by acetylcholine was always greater in the coronary vessels compared to the peripheral vessels. 3. Before heart failure, the coronary vessels were more sensitive and reactive to nitroglycerin compared to the peripheral vessels. 4. Removal of the endothelium in both the control (dogs without CHF) and experimental (dogs with CHF) rings enhanced the relaxant effects of nitroglycerin, such that the EC50 for nitroglycerin became significantly lower in all denuded rings, with the exception of the saphenous vein and the left anterior descending coronary artery, before the development of CHF. 5. When CHF was m...Continue Reading
References
Jan 1, 1978·International Anesthesiology Clinics·J B Stetson
Oct 1, 1978·American Heart Journal·J E Cottrell, H Turndorf
Dec 1, 1975·Circulation·P W ArmstrongJ O Parker
Apr 1, 1987·Journal of Cardiovascular Pharmacology·A AbdollahP W Armstrong
Oct 1, 1987·Journal of Cardiovascular Pharmacology·C R MolinaF Murad
Mar 31, 1988·Nature·M YanagisawaT Masaki
Nov 1, 1986·Circulation·P W ArmstrongA J de Bold
Feb 11, 1986·European Journal of Pharmacology·D G WhiteA H Henderson
Nov 1, 1987·Cardiovascular Research·R S ConwayS Baez
Oct 1, 1987·Circulation Research·A HartmannR J Bing
Jan 1, 1985·The Biochemical Journal·D L Aub, J W Putney
Jan 11, 1985·The American Journal of Cardiology·W W Parmley
Aug 7, 1985·European Journal of Pharmacology·Y Shirasaki, C Su
Nov 1, 1972·Circulation·H K GoldC A Sanders
Mar 18, 1983·European Journal of Pharmacology·K L Axelsson, R G Andersson
Nov 27, 1980·Nature·R F Furchgott, J V Zawadzki
Nov 1, 1983·Circulation Research·R F Furchgott
Mar 1, 1981·Circulation·J A Franciosa, J N Cohn
Oct 1, 1982·Circulation Research·J G De Mey, P M Vanhoutte
May 1, 1981·Cardiovascular Research·J S KarlinerC Dollery
Citations
Jan 1, 1992·European Journal of Clinical Pharmacology·H K IversenJ Olesen
Aug 6, 1991·European Journal of Pharmacology·C ForsterP W Armstrong
Aug 1, 1993·Journal of the American College of Cardiology·J R TeerlinkJ P Clozel
Dec 30, 1996·European Journal of Pharmacology·G Larosa, C Forster
Jul 1, 1995·Progress in Cardiovascular Diseases·S D Katz
Jan 1, 1995·Clinical and Experimental Pharmacology & Physiology. Supplement·H HigashinoA Suzuki
Jul 1, 1991·British Journal of Pharmacology·S M GardinerT Bennett
Nov 1, 1991·British Journal of Pharmacology·S M GardinerT Bennett
Jul 1, 1992·British Journal of Pharmacology·J L GarcíaG Diéguez
Jun 1, 1994·British Journal of Pharmacology·G KojdaE Noack
Nov 1, 2011·Free Radical Biology & Medicine·Mao MaoMarcelo G Bonini
Oct 11, 1996·International Journal of Cardiology·Y KhderF Zannad
Oct 1, 1994·Journal of Cardiac Failure·A J BankS H Kubo
Jan 1, 1994·Circulation·J R TeerlinkJ P Clozel
Aug 31, 2018·Cardiovascular Research·Sofia-Iris BibliIoanna Andreadou
Dec 31, 2011·Circulation Research·Matteo BerettaBernd Mayer
Jul 1, 1991·Hypertension·J M BrumC M Ferrario
Dec 1, 1993·Circulation Research·K KiuchiS F Vatner
Apr 1, 1992·Circulation·R I Ogilvie, D Zborowska-Sluis
Jun 11, 1999·The American Journal of Physiology·T MatsumotoM Kinoshita